Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

ABIDJAN-LAGOS CORRIDOR ORGANIZATION

UEI: N71RCCQ75PM7CAGE: SXQ01

ABIDJAN-LAGOS CORRIDOR ORGANIZATION is a federal contractor, registered under UEI N71RCCQ75PM7 and CAGE code SXQ01. It has been awarded $4,733,582 across 3 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Agency For International Development and Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

N71RCCQ75PM7

CAGE Code

SXQ01

Entity Structure

International Organization

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

813410Civic and Social Organizations
813990Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The ABIDJAN-LAGOS CORRIDOR ORGANIZATION operates as a nonprofit entity under NAICS 813990, which classifies it within the “Other Similar Organizations” category, typically encompassing civic, social, or advocacy groups that do not fall under traditional business or government contracting classificat...

The ABIDJAN-LAGOS CORRIDOR ORGANIZATION operates as a nonprofit entity under NAICS 813990, which classifies it within the “Other Similar Organizations” category, typically encompassing civic, social, or advocacy groups that do not fall under traditional business or government contracting classifications. Based on its structure and classification, the organization likely engages in regional coordination, stakeholder engagement, or cross-border initiative support—potentially focused on infrastructure development, trade facilitation, or transnational community programs along the Abidjan-Lagos corridor. Its technical expertise appears centered on organizational facilitation, multi-stakeholder alignment, and policy coordination rather than discrete technical services such as IT, engineering, or logistics. There is no publicly available award history to infer specific project deliverables, technical methodologies, or contractual performance outcomes. No agency relationships can be identified due to the absence of award data, and the organization does not appear to have a documented track record of federal contract performance. Its market positioning is not tied to any recognized government procurement verticals, and no certifications—such as 8(a), HUBZone, or ISO—are listed, indicating it does not currently hold formal government-recognized small business or socioeconomic designations. The entity is headquartered in Cotonou, with no additional geographic presence indicated. Its structure as an X6 entity suggests it is a nonprofit, civic association, or similar non-commercial organization. While its name implies a regional focus on West African infrastructure corridors, there is no evidence of direct engagement with U.S. federal agencies or participation in the U.S. government contracting ecosystem. The organization’s capabilities remain inferred from its classification and geographic designation, with no verifiable performance data to support specific service offerings.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Agency For International Development$3.2M66.8%
Department Of Health And Human Services$1.6M33.2%
Awards by NAICS
- Unknown NAICS$4.7M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in ABIDJAN-LAGOS CORRIDOR ORGANIZATION's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

3 months ago

DEADLINE

in 8 months
View Details